跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,447 条关于
“fibroblast growth factor receptor”
全部
31,447
临床试验
16,666
药物
2,314
机构
98
资讯
12,369
去年
FDA Grants Priority Review to Nintedanib for Idiopathic Pulmonary Fibrosis
5个月前
HARMONICARE Receives FDA Approval for FGFR2/3 Inhibitor ABSK061 Clinical Trial in Pediatric Achondroplasia
去年
Japan Recommends Approval for Brukinsa and Balversa; Grants Sakigake Designation to Brogidirsen and Iclepertin
去年
RIBOMIC's Umedaptanib Pegol Shows Promise in Phase IIa Achondroplasia Trial
去年
Swissmedic Grants Temporary Authorization to Lytgobi for FGFR2-Rearranged Cholangiocarcinoma
去年
Umedaptanib Pegol Shows Promise in Phase IIa Trial for Achondroplasia
去年
Korea Approves Voxzogo for Pediatric Chondrodysplasia Treatment
去年
Phase 1 Trial Launches to Evaluate TYRA-300 in FGFR3-Mutated Urothelial Cancer
去年
Eisai Partners with SciClone to Expand Tasurgratinib Access in Greater China for Biliary Tract Cancer Treatment
去年
TYRA-300 Shows Promise in Urothelial Cancer Treatment with Projected $63M Revenue by 2036
第 1 页，共 1237 页
上一页
下一页
